Health Blueprint

Back to Longevity News

News summary

CND Life Sciences opens new neurodiagnostics lab

Source: Longevity Technology • Published: 24 Sept 2026, 17:12

Summarized by Masters of Longevity from Longevity Technology.

A news article previewing a company’s new dedicated research lab for assay and biomarker work in neurodiagnostics, and why it matters to their product development.

CND Life Sciences opens new neurodiagnostics lab
Key Takeaways
  • CND Life Sciences opened an Innovation Laboratory in Scottsdale to host assay development and biomarker research.
  • The company’s Syn-One skin test has been used by over 3,500 clinicians in more than 70,000 patients.
  • A 2024 NIH-sponsored multicenter JAMA study found phosphorylated alpha-synuclein in 95.5% of clinically diagnosed participants.
Read the full article at Longevity Technology ↗

Continue exploring

Recommended MoL Picks

MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?MoL PickFrom Metrics to Better LivingEverstride’s May 2026 Consumer Health Market Briefing shows a wellness market moving from products to systems, from tracking to guidance, and from optimization to meaning. The next winners in longevity may not be the companies that measure the most. They may be the ones that help consumers translate health data into a life they actually want to live.